Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manja Meggendorfer

Showing results (41-50 of 125) with videos related to

Pageof 13
Sort By:
Cancer Genetics|January 26, 2020
The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: Ready for prime time?Alexander Höllein, Sven O Twardziok, Wencke Walter, et al.
Leukemia|October 9, 2025
Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutationsMaki Sakuma, Amy K Wang, Samuel J Magaziner, et al.
Leukemia|November 5, 2020
Activating JAK-mutations confer resistance to FLT3 kinase inhibitors in FLT3-ITD positive AML in vitro and in vivoChristoph Rummelt, Sivahari P Gorantla, Manja Meggendorfer, et al.
British Journal of Haematology|December 31, 2013
Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impactUlrike Bacher, Torsten Haferlach, Susanne Schnittger, et al.
Blood Advances|March 20, 2026
IDH1 and IDH2 mutated myeloid neoplasms: mutational pattern, clonal hierarchy and the role in AML transformationSandra Huber, Flora Goessweiner, Wencke Walter, et al.
Plos Computational Biology|August 31, 2019
Dark-matter matters: Discriminating subtle blood cancers using the darkest DNALaxmi Parida, Claudia Haferlach, Kahn Rhrissorrakrai, et al.
American Journal of Hematology|November 5, 2019
Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromesVikas Madan, Jia Li, Siqin Zhou, et al.
Leukemia|December 19, 2025
Solving Riddles Through Sequencing (SIRIUS): unlocking hematologic diagnoses by whole genome and transcriptome sequencingMarietta Truger, Manja Meggendorfer, Wencke Walter, et al.
Leukemia|November 18, 2025
Long read nanopore DNA sequencing with adaptive sampling to identify tyrosine kinase fusion genesMatthew Salmon, Nicole Naumann, Jenny Rinke, et al.
Seminars in Cancer Biology|June 27, 2021
Clinical utility of whole-genome sequencing in precision oncologyRichard Rosenquist, Edwin Cuppen, Reinhard Buettner, et al.
Pageof 13

Showing results (41-50 of 125) with videos related to

Sort By:
Pageof 13
Cancer Genetics|January 26, 2020
The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: Ready for prime time?Alexander Höllein, Sven O Twardziok, Wencke Walter, et al.
Leukemia|October 9, 2025
Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutationsMaki Sakuma, Amy K Wang, Samuel J Magaziner, et al.
Leukemia|November 5, 2020
Activating JAK-mutations confer resistance to FLT3 kinase inhibitors in FLT3-ITD positive AML in vitro and in vivoChristoph Rummelt, Sivahari P Gorantla, Manja Meggendorfer, et al.
British Journal of Haematology|December 31, 2013
Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impactUlrike Bacher, Torsten Haferlach, Susanne Schnittger, et al.
Blood Advances|March 20, 2026
IDH1 and IDH2 mutated myeloid neoplasms: mutational pattern, clonal hierarchy and the role in AML transformationSandra Huber, Flora Goessweiner, Wencke Walter, et al.
Plos Computational Biology|August 31, 2019
Dark-matter matters: Discriminating subtle blood cancers using the darkest DNALaxmi Parida, Claudia Haferlach, Kahn Rhrissorrakrai, et al.
American Journal of Hematology|November 5, 2019
Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromesVikas Madan, Jia Li, Siqin Zhou, et al.
Leukemia|December 19, 2025
Solving Riddles Through Sequencing (SIRIUS): unlocking hematologic diagnoses by whole genome and transcriptome sequencingMarietta Truger, Manja Meggendorfer, Wencke Walter, et al.
Leukemia|November 18, 2025
Long read nanopore DNA sequencing with adaptive sampling to identify tyrosine kinase fusion genesMatthew Salmon, Nicole Naumann, Jenny Rinke, et al.
Seminars in Cancer Biology|June 27, 2021
Clinical utility of whole-genome sequencing in precision oncologyRichard Rosenquist, Edwin Cuppen, Reinhard Buettner, et al.
Pageof 13